ClinConnect ClinConnect Logo
Search / Trial NCT06161636

Contribution of the Kinematic Theory in the Early Differential Diagnosis of the Parkinson's Disease

Launched by CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL (CHUM) · Nov 29, 2023

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how certain techniques can help doctors tell the difference between people with Parkinson's disease and those who are healthy. Researchers believe that by using automated methods to analyze movement signals, they can identify specific patterns that distinguish patients from healthy older adults. The trial aims to see which of these methods is the most reliable for diagnosing Parkinson's disease early.

To participate, you need to be between 50 and 75 years old and either have been diagnosed with Parkinsonism (which includes Parkinson's disease or similar conditions) for six years or less, or be a healthy volunteer with no history of neurological issues. Participants will undergo various assessments to help researchers gather data on movement and symptoms. It's important to note that individuals with major cognitive disorders or certain neurological conditions will not be eligible for this study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being diagnosed with Parkinsonism including idiopathic Parkinson's disease or a related syndrome;
  • Have motor symptoms of Parkinsonism for 6 years or less;
  • Be a healthy volunteer subject in good general health with no prior neurological history;
  • Age between 50-75 years old;
  • If applicable, be able to safely leave home in the morning without having taken antiparkinsonian medication for the past 12 hours.
  • Exclusion Criteria:
  • Major neurocognitive disorders;
  • History of other neurological conditions, such as ischemic or hemorrhagic stroke, paralysis of a limb, traumatic brain injury, epilepsy, orofacial dystonia, essential tremor;
  • History of oromandibular or laryngeal procedures;
  • Uncorrected deafness;
  • Any contraindication to pupillary dilation.

About Centre Hospitalier De L'université De Montréal (Chum)

The Centre Hospitalier de l'Université de Montréal (CHUM) is a leading academic health institution in Canada, dedicated to advancing patient care through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHUM is committed to leveraging its multidisciplinary expertise and state-of-the-art facilities to facilitate groundbreaking studies that enhance medical knowledge and improve health outcomes. Collaborating with a network of healthcare professionals and researchers, CHUM fosters a rigorous research environment that prioritizes patient safety, ethical standards, and scientific integrity, positioning itself at the forefront of medical advancements.

Locations

Montréal, Quebec, Canada

Patients applied

0 patients applied

Trial Officials

Pierre Blanchet

Principal Investigator

CHUM/Université de Montréal

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported